Turning Point Brands Beats Q3 2026 Estimates as Revenue Rises 27% to $151.1M

Turning Point Brands (TPB) beat estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $151.1 million, up 27% from a year earlier, above the $146.7 million estimate, and adjusted EPS was $0.41, down 61% from a year earlier, above the $0.20 estimate.

Shares fell 18% in premarket trading as of 8:01 a.m. ET, to $54.17 from a $65.88 close.

Q3 2026 scorecard

By our calculation, revenue was $4.4 million above the estimate and adjusted EPS was $0.21 above it. The QoQ column compares with the previous quarter's revenue of $143.0 million and adjusted EPS of $0.18. The YoY column compares with $119.0 million and $1.05 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 6 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 7 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $119.0 million, $121.0 million, $124.3 million, $143.0 million and $151.1 million.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $0.30 and revenue of $150.6 million next quarter, based on 2 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 27% increase to $151.1 million.
• Estimate record. Whether Turning Point Brands extends a record of beating EPS estimates in 6 of its last 8 reports.
• Related coverage. See our reports on ImmunityBio, RB Global, Roivant Sciences and Uniti.

Sources: Results are from Turning Point Brands's Nov. 9, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from Turning Point Brands's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.